Ildong's Medifoam selected as world's next-generation item

Published: 2004-07-29 06:56:00

Updated: 2004-07-29 06:56:00

The Ministry of Commerce, Industry and Energy said on July 26 that Ildong Pharm's Medifoam (hydrophilic polyurethane foam), a new wound dressing, has selected as one of Korea's global next-generation growth items and granted its certification to Park Myung-whan, its developer and president of Bio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK